Universal-Beteiligungs- und Servicegesellschaft
CORT icon

Universal-Beteiligungs- und Servicegesellschaft’s Corcept Therapeutics CORT Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
12,738
-2,739
-18% -$165K ﹤0.01% 1526
2026
Q1 		$624K Sell
15,477
-3,523
-19% -$132K ﹤0.01% 1659
2025
Q4 		$661K Sell
19,000
-46,068
-71% -$3.62M ﹤0.01% 1633
2025
Q3 		$5.41M Sell
65,068
-7,533
-10% -$545K 0.01% 836
2025
Q2 		$5.33M Buy
72,601
+54,059
+292% +$3.92M 0.01% 809
2025
Q1 		$2.12M Buy
+18,542
New +$1.13M ﹤0.01% 1169

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CORT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Corcept Therapeutics (CORT) stake by 18% in Q2 2026, selling an estimated $165K and leaving 12,738 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CORT in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.41M in Q3 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 12,738 shares of Corcept Therapeutics worth $1.11M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,739 Corcept Therapeutics shares in Q2 2026, an estimated $165K.
  • Corcept Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1526 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Corcept Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Corcept Therapeutics position peaked at $5.41M in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.